Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.270
+0.040 (3.25%)
At close: Oct 13, 2025, 4:00 PM EDT
1.260
-0.010 (-0.79%)
After-hours: Oct 13, 2025, 6:33 PM EDT
ALLO's stock price has decreased by -52.08% in the past year and price targets may not have had time to catch up.
Allogene Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$8.80
Upside
+592.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Oct 10, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 4, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 4, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +451.18% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +214.96% | May 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $10 | Strong Buy | Maintains | $14 → $10 | +687.40% | May 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +451.18% | May 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +687.40% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +608.66% | May 14, 2025 |
| Baird | Baird | Buy Maintains $12 → $9 | Buy | Maintains | $12 → $9 | +608.66% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +529.92% | Mar 19, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,002.36% | Mar 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +687.40% | Mar 14, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +293.70% | Mar 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $9 | Buy | Maintains | $11 → $9 | +608.66% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +687.40% | Nov 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.